Deutsche Bank’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Sell |
26,079
-1,093
| -4% | -$10.5K | ﹤0.01% | 2831 |
|
|
2025
Q1 | $170K | Sell |
27,172
-3,041
| -10% | -$19.1K | ﹤0.01% | 3000 |
|
|
2024
Q4 | $245K | Buy |
30,213
+9,986
| +49% | +$81.1K | ﹤0.01% | 2967 |
|
|
2024
Q3 | $366K | Buy |
20,227
+5,156
| +34% | +$93.2K | ﹤0.01% | 2589 |
|
|
2024
Q2 | $155K | Buy |
15,071
+809
| +6% | +$8.33K | ﹤0.01% | 2913 |
|
|
2024
Q1 | $151K | Sell |
14,262
-3,437
| -19% | -$36.5K | ﹤0.01% | 2934 |
|
|
2023
Q4 | $162K | Buy |
17,699
+4,870
| +38% | +$44.5K | ﹤0.01% | 2940 |
|
|
2023
Q3 | $133K | Buy |
12,829
+1,700
| +15% | +$17.6K | ﹤0.01% | 2999 |
|
|
2023
Q2 | $159K | Sell |
11,129
-5,070
| -31% | -$72.6K | ﹤0.01% | 3016 |
|
|
2023
Q1 | $116K | Buy |
16,199
+5,356
| +49% | +$38.2K | ﹤0.01% | 3255 |
|
|
2022
Q4 | $122K | Buy |
10,843
+152
| +1% | +$1.71K | ﹤0.01% | 3225 |
|
|
2022
Q3 | $118K | Buy |
10,691
+542
| +5% | +$5.98K | ﹤0.01% | 3214 |
|
|
2022
Q2 | $86K | Sell |
10,149
-1,392
| -12% | -$11.8K | ﹤0.01% | 3556 |
|
|
2022
Q1 | $157K | Sell |
11,541
-1,298
| -10% | -$17.7K | ﹤0.01% | 3360 |
|
|
2021
Q4 | $253K | Buy |
12,839
+642
| +5% | +$12.7K | ﹤0.01% | 3234 |
|
|
2021
Q3 | $392K | Sell |
12,197
-372
| -3% | -$12K | ﹤0.01% | 3175 |
|
|
2021
Q2 | $425K | Buy |
12,569
+5,144
| +69% | +$174K | ﹤0.01% | 3307 |
|
|
2021
Q1 | $279K | Sell |
7,425
-657
| -8% | -$24.7K | ﹤0.01% | 3430 |
|
|
2020
Q4 | $268K | Buy |
8,082
+2,071
| +34% | +$68.7K | ﹤0.01% | 3261 |
|
|
2020
Q3 | $220K | Buy |
6,011
+520
| +9% | +$19K | ﹤0.01% | 3130 |
|
|
2020
Q2 | $181K | Buy |
5,491
+1,781
| +48% | +$58.7K | ﹤0.01% | 3145 |
|
|
2020
Q1 | $96K | Sell |
3,710
-216
| -6% | -$5.59K | ﹤0.01% | 3219 |
|
|
2019
Q4 | $121K | Buy |
+3,926
| New | +$121K | ﹤0.01% | 3428 |
|